Omni Pharmaceuticals Team
Omni’s focus:

Specialty generic and branded pharmaceuticals featuring drug delivery systems that are difficult to develop, manufacture, and replicate for regulated markets, emerging markets and China.

Current systems:

Inhalation dry powder, nasal and HFA aerosol, and sustained release capsules and tablets.

Regulated market experience

Senior R&D managers with proven track records in bringing products to the U.S. market on behalf of top global drug makers.

Independent or Partnered:

Develops and manufactures drugs independently or with partners, including CRO, co-development and out-licensing opportunities.

Please contact: Shaochuan Zeng, Chief Operating Officer

Welcome to Shanghai Omni Pharmaceutical, for co-development, out-licensing, formulation CRO services, and independent R&D and manufacturing for NDA and ANDA projects. All products developed to meet US FDA standards with costs that are highly competitive.


中山市交通运输局民众分局(  海南广播电视总台少儿频道(  英德教育信息网(  南开招商网(  

新华通讯社( 晋城新闻网( 鞍山师范学院( 爽爽的贵阳网( 养生杂志网(